ArticleESMO open2026

Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway.

Y Matsubara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.